Innate Pharma Stock
Your prediction
Innate Pharma Stock
The Innate Pharma stock is trending slightly upwards today, with an increase of €0.015 (0.670%) compared to yesterday's price.
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | 0.670% | -0.454% | -8.159% | -18.704% | -13.752% | -38.960% | -62.733% |
| Valneva SE | -1.960% | -8.108% | -6.336% | -22.622% | -28.706% | -76.712% | 3.187% |
| Nanobiotix | -0.560% | -2.275% | -4.107% | 219.263% | -16.355% | -58.787% | -52.853% |
| Transgene S.A. | 2.740% | -11.364% | 7.537% | -34.783% | -12.687% | -52.439% | -60.606% |
